FI20011055A0 - Hevein-bindande monoklonala antikroppar - Google Patents

Hevein-bindande monoklonala antikroppar

Info

Publication number
FI20011055A0
FI20011055A0 FI20011055A FI20011055A FI20011055A0 FI 20011055 A0 FI20011055 A0 FI 20011055A0 FI 20011055 A FI20011055 A FI 20011055A FI 20011055 A FI20011055 A FI 20011055A FI 20011055 A0 FI20011055 A0 FI 20011055A0
Authority
FI
Finland
Prior art keywords
hevein
monoclonal antibodies
binding monoclonal
binding
antibodies
Prior art date
Application number
FI20011055A
Other languages
English (en)
Finnish (fi)
Other versions
FI20011055A (sv
FI112501B (sv
Inventor
Marja-Leena Laukkanen
Hans Soederlund
Soili Maekinen-Kiljunen
Tari Haahtela
Kristiina Takkinen
Original Assignee
Valtion Teknillinen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valtion Teknillinen filed Critical Valtion Teknillinen
Priority to FI20011055A priority Critical patent/FI112501B/sv
Publication of FI20011055A0 publication Critical patent/FI20011055A0/sv
Priority to US10/477,830 priority patent/US20050118161A1/en
Priority to EP02771659A priority patent/EP1392734A1/en
Priority to JP2002592352A priority patent/JP2005500826A/ja
Priority to CA002447680A priority patent/CA2447680A1/en
Priority to PCT/FI2002/000423 priority patent/WO2002094878A1/en
Publication of FI20011055A publication Critical patent/FI20011055A/sv
Application granted granted Critical
Publication of FI112501B publication Critical patent/FI112501B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI20011055A 2001-05-18 2001-05-18 Hevein-bindande monoklonala antikroppar FI112501B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20011055A FI112501B (sv) 2001-05-18 2001-05-18 Hevein-bindande monoklonala antikroppar
US10/477,830 US20050118161A1 (en) 2001-05-18 2002-05-17 Hevein-binding monoclonal antibodies
EP02771659A EP1392734A1 (en) 2001-05-18 2002-05-17 Hevein-binding monoclonal antibodies
JP2002592352A JP2005500826A (ja) 2001-05-18 2002-05-17 ヘベイン結合性モノクローナル抗体
CA002447680A CA2447680A1 (en) 2001-05-18 2002-05-17 Hevein-binding monoclonal antibodies
PCT/FI2002/000423 WO2002094878A1 (en) 2001-05-18 2002-05-17 Hevein-binding monoclonal antibodies

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20011055A FI112501B (sv) 2001-05-18 2001-05-18 Hevein-bindande monoklonala antikroppar
FI20011055 2001-05-18

Publications (3)

Publication Number Publication Date
FI20011055A0 true FI20011055A0 (sv) 2001-05-18
FI20011055A FI20011055A (sv) 2002-11-19
FI112501B FI112501B (sv) 2003-12-15

Family

ID=8561233

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011055A FI112501B (sv) 2001-05-18 2001-05-18 Hevein-bindande monoklonala antikroppar

Country Status (6)

Country Link
US (1) US20050118161A1 (sv)
EP (1) EP1392734A1 (sv)
JP (1) JP2005500826A (sv)
CA (1) CA2447680A1 (sv)
FI (1) FI112501B (sv)
WO (1) WO2002094878A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
FI20075059A0 (sv) 2007-01-29 2007-01-29 Valtion Teknillinen Allergenbindande monoklonala IgE-antikroppar och hypoaalergener:Immunokomplexinteraktion mellan typ I IgE och allergen
AU2008211807B2 (en) * 2007-01-29 2013-09-19 Valtion Teknillinen Tutkimuskeskus Method for producing novel IgE based reagents
US20120219545A1 (en) * 2009-07-31 2012-08-30 Mount Sinai School Of Medicine Materials and methods for diagnosing and treating shellfish allergy
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
ATE50144T1 (de) * 1984-07-11 1990-02-15 Univ Sydney Antiallergikum.
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
US5866344A (en) * 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
EP1269186A2 (en) * 2000-02-15 2003-01-02 Finnish Immunotechnology Ltd. Immunoassays detecting or making use of at least two rubber latex allergens

Also Published As

Publication number Publication date
JP2005500826A (ja) 2005-01-13
WO2002094878A1 (en) 2002-11-28
FI20011055A (sv) 2002-11-19
EP1392734A1 (en) 2004-03-03
FI112501B (sv) 2003-12-15
US20050118161A1 (en) 2005-06-02
CA2447680A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
EE200300179A (et) Humaniseeritud LT-ß-R-i vastased antikehad
IS6982A (is) Mótefni gegn VLA-1
DK1501856T3 (da) Anti-HER2 antistofvarianter
NO20044347L (no) Anti-alfavbeta6-antistoff
CY2012019I2 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
IS2940B (is) Mótefni gegn CD40
DK1599504T3 (da) Modificeret antistof
IL166244A0 (en) Super humanized antibodies
EP1432444A4 (en) ANTI-BETA ANTIBODIES
HK1074206A1 (en) Anti-trail-r antibodies
PT1411764E (pt) Cerca
ATE480564T1 (de) Monoklonaler anti-mensch-tenascin-antikörper
AU2002365649A8 (en) Anti-dota antibody
EE200300569A (et) CD44v6-spetsiifilised antikehad
DK1164375T3 (da) Assay til antitransglutaminaseantistoffer
NO20044145L (no) Assay for anti-INGAP antistoffer
FI20011055A0 (sv) Hevein-bindande monoklonala antikroppar
FI20020807A0 (sv) Nya humaniserade anti-VAP-1 monoklonala antikroppar
DE60232564D1 (de) Fixiergerät
ITPD20000192A0 (it) Anticorpi policlonali
EP1446416A4 (en) TUMOR-SPECIFIC MONOCLONAL ANTIBODIES
DE50115802D1 (de) Dafür
DK1503799T3 (da) Immunogent, monoklonalt antistof
GB0121727D0 (en) Monoclonal antibodies

Legal Events

Date Code Title Description
MA Patent expired